Q32 Bio (QTTB) Return on Capital Employed Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 2,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,605.00 |
| Dec 31, 2025 | 3,530.00 |
| Sep 30, 2025 | -6,279.00 |
| Jun 30, 2025 | -7,002.00 |
| Mar 31, 2025 | -6,573.00 |
| Dec 31, 2024 | -7,078.00 |
| Sep 30, 2024 | -3,666.00 |
| Jun 30, 2024 | -1,533.00 |
| Mar 31, 2024 | -4,249.00 |
| Dec 31, 2023 | -242.00 |
| Sep 30, 2023 | 11,403.00 |
| Jun 30, 2023 | 8,217.00 |
| Mar 31, 2023 | 5,806.00 |
| Dec 31, 2022 | 3,609.00 |
| Sep 30, 2022 | 1,092.00 |
| Jun 30, 2022 | 1,311.00 |
| Mar 31, 2022 | 901.00 |
| Dec 31, 2021 | 1,499.00 |
| Sep 30, 2021 | -1,999.00 |
| Jun 30, 2021 | -1,669.00 |
| Mar 31, 2021 | -1,221.00 |